Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (1)
  • 2024 (1)
  • 2023 (7)
  • 2022 (13)
  • 2021 (5)

Subject

  • Drug Trafficking (337)
  • Arrests/Convictions - Major (115)
  • Guilty Plea (107)
  • OCDETF/Task Force (73)
  • Guns/Weapons (70)
  • Synthetic drugs (61)
  • Prescription Drugs (34)
  • HIDTA (32)
  • Money Laundering (29)
  • Seizures (Drugs/Property) (28)
  • Diversion Division (24)
  • Fake Pills (23)
  • Gangs (22)
  • Take Back Day (21)
  • Task Forces/Task Force Officers (21)
  • Major Law Enforcement Operation (15)
  • Overdose (14)
  • Fentanyl Awareness (9)
  • Outreach/Drug Prevention (9)
  • Extraditions (6)
  • Press Conferences (6)
  • International/Foreign Operations (5)
  • One Pill Can Kill (5)
  • Asset Forfeiture (4)
  • Dark Web- Internet Trafficking (4)
  • Prevention/Education - DEA websites GSAD, JTT etc (4)
  • Public and Media Affairs - also see Congressional Affairs (4)
  • Intergovernmental Affairs (2)
  • Fentanyl Free America (1)
  • Intelligence Division - Intelligence Products (1)
  • Other (1)
  • Terrorism (1)
  • Pharmaceuticals/Pharmacists/Physicians (27)

Drug Name

  • Oxycodone (6)
  • Opioids (5)
  • Amphetamines (2)
  • Hydromorphone (2)
  • Benzodiazepines (1)
  • Synthetic Opioids (1)

Field Division

  • Washington, DC (35)
  • St. Louis (32)
  • New York (21)
  • Chicago (19)
  • Atlanta (12)
  • El Paso (10)
  • Seattle (9)
  • Sede (9)
  • Dallas (8)
  • Houston (7)
  • San Francisco (7)
  • Louisville (5)
  • New England (5)
  • San Diego (5)
  • Los Angeles (4)
  • New Orleans (4)
  • Rocky Mountain (3)
  • Omaha (2)
  • Phoenix (2)
  • Philadelphia (1)
  • Miami (16)
  • New Jersey (11)
Clear All Results
27 Results - Showing 1 to 10
PRESS RELEASE

California Couple Sentenced to Prison for Mail Order Drug Trafficking

MIAMI – A federal district judge in Ft. Pierce sentenced a husband and wife to federal prison yesterday for working with a foreign drug trafficking organization to distribute methamphetamine, opioids, and other controlled drugs purchased by customers from an online pharmacy. U.S. District Judge Aileen M. Cannon sentenced Vanessa Vanly...
PRESS RELEASE

Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations

NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...
PRESS RELEASE

Passaic County Doctor Charged in Conspiracy to Distribute Opioids

NEWARK, N.J. – A Passaic County, New Jersey, doctor was charged with conspiring to distribute opioids without a legitimate medical reason, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Field Division Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced. Lisa Ferraro, 65, of Hillsdale, New...
PRESS RELEASE

Toms River Woman Charged with Unauthorized Practice of Medicine, Forgery, Health Care Claims Fraud, and Distribution of a Controlled Dangerous Substance

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Division Cheryl Ortiz and Ocean County Prosecutor Bradley D. Billhimer announced that on July 25, 2023, Maria F. Macburnie, aka Marife L. Macburnie, 62, of Toms River, was charged with Practicing Medicine by an Unlicensed...
PRESS RELEASE

Jury Convicts Pain Clinic Doctor of Unlawful Drug Distribution, Money Laundering, and Filing a False Tax Return

TAMPA , F la. – United States Attorney Roger B. Handberg announced that a federal jury found Dr. Qing McGaha guilty of 14 counts of unlawful drug distribution, four (4) counts of money laundering, and one (1) count of filing a false tax return. McGaha faces a maximum penalty of...
PRESS RELEASE

Panama City Physician Pays $225,000 to Settle Allegations that He Overprescribed Controlled Substances

PENSACOLA, Fla. – Dr. George Barrio, a pain management physician who formerly practiced medicine at the NeuroMedical Institute in Panama City, agreed to pay $225,000 to resolve allegations that he unlawfully prescribed opioids and other controlled substances to patients. The settlement was announced by Jason R. Coody, United States Attorney...
PRESS RELEASE

Physician Agrees to $190,731 Settlement Relating to Controlled Substances Act Claims

PENSACOLA, Fla. – Timothy Ramsden, of Panama City, Florida, practicing at The Anti-Aging Clinic of Northwest Florida, settled potential violations of the Controlled Substances Act by agreeing to pay a fine of $190,731 and surrendering his Drug Enforcement Administration (DEA) registration for Schedule II and IIN controlled substances for a...
PRESS RELEASE

Former Office Manager of New Jersey Medical Practice Admits Conspiring with Doctor to Divert Controlled Substances

NEWARK, N.J. – Acting Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Daniel J. Kafafian and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a former office manager of a New Jersey medical practice admitted conspiring with the doctor who owned the...
PRESS RELEASE

South Florida Doctor Sentenced to Prison for Unlawfully Dispensing Narcotics

MIAMI – Dr. Ronald Lubetsky was sentenced this week to five (5) years in prison by U.S. District Judge Donald M. Middlebrooks for unlawfully dispensing narcotics—specifically oxycodone and morphine. Lubetsky was convicted at trial in November on seven counts of unlawfully dispensing narcotics. Trial evidence showed that law enforcement learned...
PRESS RELEASE

Department of Justice Files Nationwide Lawsuit Against Amerisource Bergen Corp. and Subsidiaries for Controlled Substances Act Violations

NEWARK, N.J. – In a civil complaint filed today, the Department of Justice alleges that AmerisourceBergen Corp. and two of its subsidiaries, AmerisourceBergen Drug Corp. and Integrated Commercialization Solutions LLC (AmerisourceBergen), collectively one of the country’s largest wholesale pharmaceutical distributors and one of the largest companies in America by revenue...

Paginación

  • Current page 1
  • Page 2
  • Page 3
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster